1 / 11

Europe Platelet Rich Plasma (PRP) Market worth US$ 35.3 Mn in 2015

The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.

Ethan_smith
Download Presentation

Europe Platelet Rich Plasma (PRP) Market worth US$ 35.3 Mn in 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Report Id :REP-EU-1599 Published On :June-2016 Category :Healthcare, Pharmaceuticals and Medical devices Platelet Rich Plasma (PRP) Market: EuropeIndustry Analysis and Opportunity Assessment 2016 - 2024

  2. AboutFuture Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Subscription Information Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Customized Research Syndicated Research Investment Research Social Media Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

  3. Research Methodology (1/2) Market Profiling Formulating discussion guide Developing list of respondents Data Collection Data Validation Data Analysis Research & Intelligence Data Collection Actionable Insights Data Filter & Analysis Business Solution 1 2 • Identifying key opinion leaders • Questionnaire design • In depth interviews • Coverage across value chain 3 • Key Industry Experts • Channel Study • Developments • Market Dynamics • Products • Conclusions A 4 Primary Research SOLUTION • Market Participants • Key Strengths • Product Portfolio • Mapping as per value chain • Key focus segments B 5 Desk Research 6 C Paid Publications# Primary Research # Secondary Research # Company Analysis 7 • Factiva • GBI • Genios • Meltwater • Linkedin • Zoominfo • Salesforce • Hoovers • Onesource • Company Websites • Company Annual Reports • White Papers • Financial Reports Insights # includes sources of databases

  4. Platelet Rich Plasma (PRP) Market Adoption of Platelet Rich Plasma Growing in Europe on Account of its Efficacy in Treating Osteoarthritis and Tennis Elbow: Study The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time. By product type, PRP kits will continue to outsell instruments, accounting for over 75% revenue share of the market in 2016. Among the various platelet rich plasma kits, autologous kits will account for the highest demand on the basis of blood type, representing a market value worth US$ 24.2 Mn. P-PRF kits—valued at US$ 10 Mn in 2015—will witness the highest growth by end-product type, increasing at 8.6% in 2016. By application, adoption of PRP therapy will continue to remain highest in the treatment of knee and elbow injuries. While knee application segment revenues will grow by 7.2%, elbow application segment revenues are projected to grow by 6.3%. Use of PRP therapy in the treatment of ever-increasing incidences of osteoarthritis and tennis elbow will gain further traction in 2016 and beyond.

  5. Platelet Rich Plasma (PRP) Market Request Free Report Sample@http://www.futuremarketinsights.com/reports/sample/rep-eu-1599 PRP revenues in the UK—the largest market in Europe—will grow by 7.3% in 2016, an increase of 0.20% from the 7.1% growth in 2015. High prevalence of sports-related incidents in the U.K., combined with high awareness about the benefits of PRP therapy among healthcare community and patients, will continue to fuel the growth of the market in the country. France will maintain its position as the second largest market for PRP in Europe, growing by 6.5% in terms of revenues in 2016. France is home to subsidiaries and distributors of several PRP players, such as Biomet, Inc., DePuySynthes, Inc., and Stryker Corporation and a range of highly innovative products are available in the market. Johnson & Johnson Inc. and Stryker Corporation are the established players in the Europe PRP market. Johnson & Johnson’s PEAK™ Platelet Rich Plasma System and Stryker Corporation’s RegenKit THT Autologous Platelet-rich Plasma (A-PRP) will continue to witness sizeable sales in 2016. Arthrex - Arthrex Angel System™ from Arthrex Inc. and GPS® III Platelet Separation System by Zimmer Biomet Holdings Inc. will also account for substantial revenue share of the Europe PRP market.

  6. Platelet Rich Plasma (PRP) Market Request For TOC@http://www.futuremarketinsights.com/toc/rep-eu-1599 Long-term Outlook: The PRP market in Europe is expected to increase at a CAGR of 6.6% during the forecast period 2016-2024. The UK will continue to be at the forefront of overall demand, with France and Germany accounting for sizeable market share. While FMI maintains a positive outlook on the Europe PRP market, challenges, including lack of standardisation in preparation and dosage of autologous blood concentrate, and uncertainty about therapy efficacy can impede growth during the forecast period.

  7. Table of Content 1.Research Methodology 2.Assumptions & Acronyms Used 3.Executive Summary 4.Platelet Rich Plasma Market overview 4.1.Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%) 4.2.Principle Growth Factors in PRP 5.Europe Platelet Rich Plasma Market Definitions 6.Platelet Rich Plasma Market : PEST Analysis and Key Regulations 7.Europe Platelet-rich Plasma Market Dynamics

  8. Table of Content • 7.1.Drivers • 7.2.Restraints • 7.3.Opportunities • 7.4.Trends • 8.Europe Platelet-rich Plasma (PRP) Market Revenue, by Product Type, 2013–2024 • 8.1.Introduction • 8.1.1. Europe PRP Market Value Share & BPS Analysis, by Product Type, 2014 & 2024 • 8.1.2. Europe PRP Market Y-o-Y Growth Comparison, by Product Type, 2013–2024 • 8.2.Market Value Forecast, By Product Type

  9. Table of Content • 8.2.2. Kits • 8.2.2.1.Y-o-Y Growth Comparison • 8.2.2.2.Market Value Forecast • 8.2.2.3.Pure-Platelet Rich Plasma (P-PRP) Kits Sub-segment • 8.2.2.3.1.Y-o-Y Growth Comparison • 8.2.2.3.2.Market Value Forecast • 8.2.2.4.Leukocyte-rich Platelet-rich Plasma (L-PRP) Kits Sub-segment • 8.2.2.4.1.Y-o-Y Growth Comparison • 8.2.2.4.2.Market Value Forecast • 8.2.2.5.Leukocyte-Platelet-rich Fibrin (L-PRF) Kits Sub-segment • 8.2.2.5.1.Y-o-Y Growth Comparison • 8.2.2.5.2.Market Value Forecast • 8.2.2.6.Pure- Platelet-rich Fibrin (P-PRF) Kits Sub-segment • 8.2.2.6.1.Y-o-Y Growth Comparison • 8.2.2.6.2.Market Value Forecast

  10. Table of Content • 8.2.2.7.Autologous Platelet-rich Plasma Kits Sub-segment • 8.2.2.7.1.Y-o-Y Growth Comparison • 8.2.2.7.2.Market Value Forecast • 8.2.2.8.Homologous Platelet-rich Plasma Kits Sub-segment • 8.2.2.8.1.Y-o-Y Growth Comparison • 8.2.2.8.2.Market Value Forecast • 8.2.2.9.Allogeneic Platelet-rich Plasma Kits Sub-segment • 8.2.2.9.1.Y-o-Y Growth Comparison • 8.2.2.9.2.Market Value Forecast • For more insights on the Europe Platelet-rich Plasma (PRP) Market, you can request a report sample with full TOC at http://www.futuremarketinsights.com/reports/sample/rep-eu-1599

  11. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights:3rd Floor, 207 Regent Street, London W1B 3HH T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

More Related